Literature DB >> 12884159

Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System.

Emily Jane Woo1, Dale R Burwen, Sarah N M Gatumu, Robert Ball.   

Abstract

Extensive limb swelling (ELS) has been reported after vaccination with a limited number of vaccine types. We sought to describe vaccine types involved in and the clinical characteristics of ELS cases reported to the Vaccine Adverse Event Reporting System (VAERS). A case of ELS was defined as any report of edema extending at least to the elbow or knee of a vaccinated extremity. Four hundred ninety-seven cases were identified, with some describing swelling from the shoulder to the hand or the hip to the foot. Patient age ranged from 0.1 to 91 years. The proportion of reports of ELS associated with a given vaccine, among all VAERS reports received for that vaccine, varied substantially among vaccines. Most reactions began within 1 day after vaccination and involved other signs of inflammation. Postvaccination ELS can involve both the proximal and distal segments of the extremity, affects all age groups, and occurs after vaccination with a broad range of vaccines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884159     DOI: 10.1086/375820

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  12 in total

1.  Vaccine-induced myositis with intramuscular sterile abscess formation: MRI and ultrasound findings.

Authors:  Ahmet Veysel Polat; Tumay Bekci; Nevzat Dabak; Esra Meltem Kayahan Ulu; Mustafa Bekir Selcuk
Journal:  Skeletal Radiol       Date:  2015-08-26       Impact factor: 2.199

Review 2.  Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.

Authors:  S Elizabeth Williams; Nicola P Klein; Neal Halsey; Cornelia L Dekker; Roger P Baxter; Colin D Marchant; Philip S LaRussa; Robert C Sparks; Jerome I Tokars; Barbara A Pahud; Laurie Aukes; Kathleen Jakob; Silvia Coronel; Howard Choi; Barbara A Slade; Kathryn M Edwards
Journal:  Vaccine       Date:  2011-07-27       Impact factor: 3.641

Review 3.  Acellular pertussis vaccine safety and efficacy in children, adolescents and adults.

Authors:  Janet R Casey; Michael E Pichichero
Journal:  Drugs       Date:  2005       Impact factor: 9.546

4.  Booster vaccination and 1-year follow-up of 4-8-year-old children with a reduced-antigen-content dTpa-IPV vaccine.

Authors:  Roland Sänger; Ulrich Behre; Karl-Heinz Krause; Hans-Peter Loch; Peter Soemantri; Dietmar Herrmann; Eugenie Schmitz-Hauss; Joanne Wolter; Bernard Hoet
Journal:  Eur J Pediatr       Date:  2007-01-18       Impact factor: 3.183

5.  Successful Treatment of Delayed Localized Necrotizing Inflammatory Myositis After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine: A Case Report.

Authors:  Jennifer Chen Li; Jonathan Siglin; Michael S Marshall; Anat Stemmer-Rachamimov; Seth M Bloom; Kimberly G Blumenthal
Journal:  Open Forum Infect Dis       Date:  2022-09-27       Impact factor: 4.423

6.  Canadian Adverse Events Following Immunization Surveillance System (CAEFISS): Annual report for vaccines administered in 2012.

Authors:  B J Law; J Laflèche; N Ahmadipour; H Anyoti
Journal:  Can Commun Dis Rep       Date:  2014-12-04

Review 7.  Update on side effects from common vaccines.

Authors:  Benjamin J Song; Rohit K Katial
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

8.  Herpes zoster vaccine (Zostavax®): Cellulitic injection site reaction or bacterial cellulitis?

Authors:  Ian F Cook
Journal:  Hum Vaccin Immunother       Date:  2016-10-27       Impact factor: 3.452

9.  Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study.

Authors:  Lisa A Jackson; Onchee Yu; Edward A Belongia; Simon J Hambidge; Jennifer Nelson; Roger Baxter; Allison Naleway; Charlene Gay; James Nordin; James Baggs; John Iskander
Journal:  BMC Infect Dis       Date:  2009-10-05       Impact factor: 3.090

10.  Immunization Catch-Up for Newly Arrived Migrants in France: A Cross-Sectional Study among French General Practitioners.

Authors:  Sohela Moussaoui; Anne Marie Aurousseau; Sylvain Nappez; Julian Cornaglia; Gaylord Delobre; Sophie Blanchi; Louise Luan; Stéphanie Vandentorren; Olivier Bouchaud; Odile Launay; Louise Nutte; Roxane Liard; Mariela Skendi; Matthieu Mechain; Nicolas Vignier
Journal:  Vaccines (Basel)       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.